Randomized control trial comparing effect of Prolotherapy with two different concentrations of dextrose in treating myofascial pain syndrome

Comparative study of 5% dextrose vs 18% dextrose prolotherapy in Myofascial pain syndrome

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076304

Enrollment

Registered

2024-11-05

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M798- Other specified soft tissue disorders

Interventions

Intervention1: Dextrose Prolotherapy: 2 different concentration of Dextrose will be administered based on randomisation, to patients diagnosed with Myofascial pain syndrome Injection will be intramusc

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Myofascial pain syndrome with VAS >5 and those who are consenting to procedure are included in my study

Exclusion criteria

Exclusion criteria: 1.Fibromyalgia 2.Psychiatric pain disorders 3.Other Ortho/Neurological conditions causing pain 4.Pediatric population

Design outcomes

Primary

Measure	Time frame
5% Dextrose provide better relief to myofascial pain compared to 18% DextroseTimepoint: 0, 1 and 3 months post injection, patient will be assessed	—

Secondary

Measure	Time frame
Reduction in myofascial trigger point countTimepoint: 1 and 3 months after intervention	—

Countries

India

Contacts

Public ContactDr Harinath S

Amrita Institute of Medical Sciences

ravisankaran@aims.amrita.edu04842851234

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026